Adipocytokines and cancer

被引:224
作者
Housa, D.
Housova, J.
Vernerova, Z.
Haluzik, M. [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Dept Med 3, U Nemocnice 1, Prague 12800 2, Czech Republic
[2] Charles Univ Prague, Gen Univ Hosp, Prague 12800 2, Czech Republic
[3] Fac Med 3, Dept Pathol, Prague, Czech Republic
[4] Univ Hosp Kralovske Vinohrady, Prague, Czech Republic
关键词
obesity; adipocytokine; leptin; adiponectin; cancer; adipose tissue;
D O I
10.33549/physiolres.930848
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Adipose tissue-produced hormones significantly affect the metabolism of lipids and carbohydrates as well as numerous other processes in human body. It is generally accepted that endocrine dysfunction of adipose tissue may represent one of the causal links between obesity and insulin resistance/diabetes. Epidemiological studies underlined that obesity represents a significant risk factor for the development of cancer, although the exact mechanism of this relationship remains to be determined. Multiple recent studies have indicated that some of adipose tissue-derived hormones may significantly influence the growth and proliferation of tumorous stroma and malignant cells within. Here we review current knowledge about possible relationship of leptin and adiponectin to the etiopathogenesis of different malignant tumors. Most of the studies indicated that while leptin may potentiate the growth of cancer cells in vitro, adiponectin appears to have an opposite effect. Further studies are necessary to decide whether obesity-induced endocrine dysfunction of adipose tissue can directly influence carcinogenesis in different tissues and organs.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 84 条
[21]   The changes of serum leptin and soluble leptin receptor levels in patients undergoing mobilization of peripheral blood stem cells before autologous stem cells transplantation [J].
Haluzik, M ;
Markova, M ;
Slaby, J ;
Jiskra, J ;
Krizova, J ;
Haas, T .
ENDOCRINE RESEARCH, 2002, 28 (03) :189-197
[22]   Leptin is a growth factor for colonic epithelial cells [J].
Hardwick, JCH ;
Van den Brink, GR ;
Offerhaus, GJ ;
Van Deventer, SJH ;
Peppelenbosch, MP .
GASTROENTEROLOGY, 2001, 121 (01) :79-90
[23]   Prostate cancer risk and serum levels of insulin and leptin: a population-based study [J].
Hsing, AW ;
Chua, S ;
Gao, YT ;
Gentzschein, E ;
Chang, L ;
Deng, J ;
Stanczyk, FZ .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (10) :783-789
[24]   AdipoQ is a novel adipose-specific gene dysregulated in obesity [J].
Hu, E ;
Liang, P ;
Spiegelman, BM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (18) :10697-10703
[25]   Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging [J].
Hubbard, JS ;
Rohrmann, S ;
Landis, PK ;
Metter, EJ ;
Muller, DC ;
Andres, R ;
Carter, HB ;
Platz, EA .
UROLOGY, 2004, 63 (02) :253-258
[26]   Visfatin: A new adipokine [J].
Hug, C ;
Lodish, HF .
SCIENCE, 2005, 307 (5708) :366-367
[27]  
Ishikawa M, 2005, CLIN CANCER RES, V11, P466
[28]  
Janecková R, 2001, PHYSIOL RES, V50, P443
[29]   Obesity and hormone-dependent tumors: Cohort and co-twin control studies based on the Swedish Twin Registry [J].
Jonsson, F ;
Wolk, A ;
Pedersen, NL ;
Lichtenstein, P ;
Terry, P ;
Ahlbom, A ;
Feychting, M .
INTERNATIONAL JOURNAL OF CANCER, 2003, 106 (04) :594-599
[30]   Expression of leptin receptor in human endometrium and fluctuation during the menstrual cycle [J].
Kitawaki, J ;
Koshiba, H ;
Ishihara, H ;
Kusuki, I ;
Tsukamoto, K ;
Honjo, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05) :1946-1950